Multiple myeloma
Multiple myeloma is a cancer of the blood. It develops in plasma cells, which are white blood cells that help fight infection. In multiple myeloma, cancer cells build up in bone marrow and take over the healthy blood cells.
Showing all 9 results
-
BLENREP (belantamab mafodotin-blmf) for injection, for intravenous use. Initial U.S. Approval: 2020
-
Bortenat (bortezomib) Injection
-
Carfilnat (carfilzomib)
-
Darzalex (daratumumab) Injection
-
DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) injection, for subcutaneous use
-
NINLARO (ixazomib) capsules, for oral use. Initial U.S. Approval: 2015
-
Pomalid (pomalidomide) Capsules
-
POMALYST (pomalidomide) capsules, for oral use. Initial US Approval: 2013
-
REVLIMID [lenalidomide] capsules, for oral use. Initial US Approval: 2005